Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.

MLA

Mistry, Pramod K., et al. “Long-Term Effectiveness of Eliglustat Treatment: A Real-World Analysis from the International Collaborative Gaucher Group Gaucher Registry.” American Journal of Hematology, vol. 99, no. 8, Aug. 2024, pp. 1500–10. EBSCOhost, https://doi.org/10.1002/ajh.27347.

APA

Mistry, P. K., Balwani, M., Charrow, J., Lorber, J., Niederau, C., Carwile, J. L., Oliveira-Dos-Santos, A., Perichon, M. G., Uslu Cil, S., & Kishnani, P. S. (2024). Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher Registry. American Journal of Hematology, 99(8), 1500–1510. https://doi.org/10.1002/ajh.27347

Chicago

Mistry, Pramod K, Manisha Balwani, Joel Charrow, Jeremy Lorber, Claus Niederau, Jenny L Carwile, Antonio Oliveira-Dos-Santos, Maria Gabriela Perichon, Sefika Uslu Cil, and Priya S Kishnani. 2024. “Long-Term Effectiveness of Eliglustat Treatment: A Real-World Analysis from the International Collaborative Gaucher Group Gaucher Registry.” American Journal of Hematology 99 (8): 1500–1510. doi:10.1002/ajh.27347.